Lawsuit Alleges Medtronic Illegally Marketed Stent Device For Unapproved Use

email to a friend

printer friendly

opinions

Current Article Ratings:

Patient / Public:
Healthcare Prof:

A complaint filed in federal court last week "alleges Medtronic Inc. illegally marketed a relatively obscure medical device called a biliary stent in ways not approved by federal regulators," The (Minneapolis-St. Paul) Star Tribune reports. "The complaint was filed in U.S. District Court in Boston by two former employees who claim they were harassed and then fired by the Fridley-based medical technology giant when they complained to their managers that so-called 'off-label' use of the stent could be harmful to patients." The whistleblowers allege that Medtronic "pressured and incentivized" its salespeople to push the device's use to treat vascular conditions instead of for their approved use related to tumors in several organs (Moore, 2/24).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

• Additional
• References
• Citations